Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
For 10 mg/mL, add 6 mL
But Lilly appears to have calculated that a proven, convenient, well-absorbed oral GLP-1 is more valuable than a hypothetical oral dual agonist with uncertain absorption
(2017) "Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial" The Lancet Diabetes & Endocrinology, 5(4) This article was reviewed by and approved by Alice Fletcher, Lead Bariatric Dietitian, on 3 April 2025
Not only it has been shown to reverse insulin resistance in treatment-resistant bipolar depression while improving clinical outcomes, but it is also well-tolerated and affordable (McIntyre et al
Aronne reports receiving grants or personal fees from Altimmune, AstraZeneca, Boehringer Ingelheim, Eli Lilly, ERX, Gelesis, Intellihealth, Jamieson Wellness, Janssen, Novo Nordisk, Optum, Pfizer, Senda Biosciences, and Versanis and being a shareholder of Allurion, ERX Pharmaceuticals, Gelesis, Intellihealth, and Jamieson Wellness
